Oral Abstract Session:
217. Zika - A to Z
Saturday, October 7, 2017: 8:30 AM-10:00 AM
Room: 02

Tracks: Global ID, Adult ID

Moderators:  Wesley Van Voorhis, MD, PhD, FIDSA, University of Washington and Roberta DeBiasi, MD, MS, FIDSA, FPIDS, Childrens National Health System/GWU School of Medicine

8:30 AM
Galidesivir, a direct-acting antiviral drug, abrogates viremia in Rhesus macaques challenged with Zika virus
So-Yon Lim, Ph.D.; Christa Osuna, Ph.D.; Jessica Lakritz, Ph.D.; Elsa Chen, M.Sc.; Gyeol Yoon, M.Sc.; Ray Taylor, MBA; Steve MacLennan, Ph.D.; Michael Leonard, Ph.D.; Enzo Giuliano, Ph.D.; Amanda Mathis, Ph.D.; Elliot Berger, Ph.D.; Ys Babu, Ph.D.; William Sheridan, MB BS; James Whitney, Ph.D.
8:45 AM
Outcomes of women with laboratory evidence of Zika infection in pregnancy
Naiomi Gunaratne, BS; Michelle Bartlett, BA; Anise Crane, BS; Samantha Greissman, BA, MPH; Jaclyn Kwal, BA; Meghan Lardy, BS; Michelle Picon, MD; Rebecca Starker, BS; Colette Tse, BA; Patricia Rodriguez, MD; Ivan Gonzalez, MD; Christine Curry, MD, PhD
9:00 AM
Environmental and Climatic Risk Factors for Zika and Chikungunya Virus Infections in Rio de Janeiro, Brazil, 2015-16
Trevon Fuller, PhD, MA; Guilherme A. Calvet, MD, PhD; Camila Genaro Estevam, BS; Patricia Brasil, MD, PhD; Jussara Rafael Angelo, PhD, MPH; Thomas B. Smith, PhD, MS; Ana M. Bispo Di Filippis, PhD; Karin Nielsen-Saines, MD, MPH
9:15 AM
Differential Neuronal Susceptibility and Apoptosis in Congenital Zika Virus Infection
Cheng-Ying Ho, MD, PhD; Heather Ames, MD, PhD; Ashley Tipton, BS; Gilbert Vezina, MD; Judy Liu, MD, PhD; Joseph Scafidi, DO; Masaaki Torii, PhD; Fausto Rodriguez, MD; Adre duPlessis, MB, ChB; Roberta DeBiasi, MD, MS, FIDSA, FPIDS
9:30 AM
Risk Factors Associated with Persistence of Zika Virus Nucleic Acid in Serum and Semen
Matthew Lozier, PhD; Eli Rosenberg, PhD; Katherine Doyle, MPH; Laura Adams, DVM MPH; Liore Klein, MSPH; Jorge Muñoz-Jordan, PhD; Luisa I. Alvarado, MD, FAAP; Tyler Sharp, PhD; Gabriela Paz-Bailey, MD PhD

CME Credits: No CME credit is offered for this session.

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.